About
Our Story
Honorary President
Big Issue
Team
Consultants
Investment
Stretagies
Portfolio
Pharmacetical
Corporate Governance
Board of Directors
Audit Committee
Remuneration Committee
Internal Audit
Major Internal Policies
ESG
Overview
Sustainable Governance
Environment Mangement
Diversity, Equity & Inclusion
Social Relationships
Downloads
Investors
Financials
Financial Reports
Operating Revenue
Events
Market Observation Post System
News
Careers
Job Openings
Contact
繁體中文
Investors
Operating Revenue
Year
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Unit: Thousands of NTD
Month
Consolidated
Net revenue
YOY%
1
152,569
39
2
93,994
-23
3
116,847
12
Total
363,410
8%